Bank of New York Mellon Corp Trims Stake in agilon health, inc. (NYSE:AGL)

Bank of New York Mellon Corp reduced its position in agilon health, inc. (NYSE:AGL) by 9.1% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 774,802 shares of the company’s stock after selling 77,150 shares during the period. Bank of New York Mellon Corp owned 0.19% of agilon health worth $1,472,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. JPMorgan Chase & Co. lifted its holdings in shares of agilon health by 326.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock valued at $5,563,000 after purchasing an additional 1,083,492 shares during the last quarter. Inspire Investing LLC lifted its holdings in shares of agilon health by 106.6% in the 4th quarter. Inspire Investing LLC now owns 217,550 shares of the company’s stock valued at $413,000 after purchasing an additional 112,241 shares during the last quarter. Citigroup Inc. raised its stake in agilon health by 2,251.5% during the 3rd quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock valued at $7,971,000 after acquiring an additional 1,941,993 shares during the last quarter. Geode Capital Management LLC raised its stake in agilon health by 1.2% during the 3rd quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company’s stock valued at $27,097,000 after acquiring an additional 84,889 shares during the last quarter. Finally, Empowered Funds LLC purchased a new stake in agilon health during the 4th quarter valued at approximately $97,000.

Analyst Ratings Changes

Several analysts have commented on the company. Macquarie assumed coverage on agilon health in a research note on Monday, December 16th. They set a “neutral” rating and a $3.00 price objective for the company. Needham & Company LLC reaffirmed a “hold” rating on shares of agilon health in a research note on Friday. Stifel Nicolaus upped their price objective on agilon health from $2.00 to $3.00 and gave the company a “hold” rating in a research note on Wednesday, February 26th. Citigroup raised agilon health from a “sell” rating to a “neutral” rating and upped their price objective for the company from $1.75 to $2.25 in a research note on Friday, January 10th. Finally, Sanford C. Bernstein upped their price objective on agilon health from $2.50 to $3.15 and gave the company a “market perform” rating in a research note on Wednesday, January 15th. Two investment analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, agilon health has a consensus rating of “Hold” and a consensus target price of $3.95.

agilon health Stock Performance

AGL opened at $4.51 on Friday. The stock has a market cap of $1.86 billion, a P/E ratio of -4.80 and a beta of 0.67. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. The stock’s 50 day simple moving average is $3.51 and its 200 day simple moving average is $2.95. agilon health, inc. has a 1-year low of $1.50 and a 1-year high of $7.73.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.